Exact Mass: 339.1859144

N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

Perazine

10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine

C20H25N3S (339.176909)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

Xamoterol

Xamoterol hemifumarate

C16H25N3O5 (339.179412)

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Same as: D06328

NCIOpen2_009010

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

Methylergonovine

Methylergometrine

G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

Methylergonovine

(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

Methylergonovine is only found in individuals that have used or taken this drug. It is a homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)Methylergonovine acts directly on the smooth muscle of the uterus and increases the tone, rate, and amplitude of rhythmic contractions through binding and the resultant antagonism of the dopamine D1 receptor. Thus, it induces a rapid and sustained tetanic uterotonic effect which shortens the third stage of labor and reduces blood loss. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

Dehydropipernonaline is found in herbs and spices. Dehydropipernonaline is isolated from fruits of Piper longum (long pepper). Isolated from fruits of Piper longum (long pepper). Dehydropipernonaline is found in herbs and spices and pepper (spice).

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C18H26FNO4 (339.18457680000006)

Edivoxetine

(R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol

1',3'-Dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one

1,5-dimethyl-17-oxa-7-azaspiro[1,5-diazinane-2,4-tetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadecane]-1(10),11,13,15-tetraen-6-one

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

Nalmefene

4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

Pimelic Diphenylamide 106

N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide

His Gly Leu

Gly His Leu

BML-210

N-(2-aminophenyl)-N-phenyl-octanediamide

Gly Leu His

Ala His Ile

Methylergometrine

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.459 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.450 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451

Leu Ala His

His Ile Ala

Ala Leu His

Leu His Ala

His Leu Ala

Dextromoramide M4

Poldine

Ala His Leu

Ile Ala His

His Ala Leu

mepenzolate

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

Piperilate

2-piperidin-1-ylethyl 2-hydroxy-2,2-diphenylacetate

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

C18H27ClFN3 (339.1877424)

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

C21H25NO3+ (339.18343400000003)

azanium,cumene,furan-2,5-dione,styrene

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)

4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)MORPHOLINE HYDROCHLORIDE

C17H27BClNO3 (339.1772412)

Fmoc-Ile-ol

3-(4-MORPHOLINOMETHYL)-PHENYLBORONIC ACID PINACOL ESTER HYDROCHLORIDE

C17H27BClNO3 (339.1772412)

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

6-(fmoc-amino)-1-hexanol

FMOC-LEU-OL

ORG-25935 free base

C18H26FNO4 (339.18457680000006)

Edivoxetine

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

N1-(2-aminophenyl)-N8-phenyloctanediamide

D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

4-benzyl-N-(2,4-dimethylphenyl)piperazine-1-carbothioamide

C20H25N3S (339.176909)

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

Ala-His-Leu

His-Ala-Ile

Ala-Leu-His

His-Ala-Leu

His-Leu-Ala

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

Ile-His-Ala

Leu-Ala-His

His-Ile-Ala

Ala-His-Ile

Ile-Ala-His

Leu-His-Ala

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

PF-670462 free base(2+)

C19H22FN5+2 (339.1859144)

PERAZINE

C20H25N3S (339.176909)

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Methergine

D012102 - Reproductive Control Agents > D010120 - Oxytocics

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

Ala-Ile-His

KYP-2047

KYP-2047 is a potent and BBB-penetrating prolyl-oligopeptidase (POP) inhibitor, with an Ki value of 0.023 nM. KYP-2047 reduces glioblastoma proliferation through angiogenesis and apoptosis modulation[1][2].

SEN12333

SEN 12333 (WAY-317538) is a potent, selective and orally active α7 nAChR agonist. SEN12333 displays high affinity for the rat α7 nAChRs expressed in GH4C1 cells (K>i=260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50=1.6 μM). SEN 12333 is used for AD and schizophrenia research[1].

(1s,5r,8r,9s,11r,14s,17s,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

(1r,5r,8r,9s,11s,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

(4s,5r,8r,9s,10s)-3-hydroxy-5,9-dimethyl-14-oxa-7-azahexacyclo[15.2.1.1⁷,¹⁰.0⁴,⁸.0⁹,¹⁹.0¹³,¹⁸]henicosa-1(19),13(18),17(20)-trien-2-one

(6s,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol